10 employees
Oncotect is a Raleigh-based biotech startup committed to pioneering early screening of cancer risks in dogs using their urine.
2020
$200K
from 2 investors over 2 rounds
Oncotect raised $200K on February 27, 2023
Investors: Leap Venture Studio & Academy
Oncotect raised $100K on November 9, 2022
Investors: North Carolina Biotechnology Center (NCBiotech)